IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Industrial Biotech

Excelsyn Mulls Technology Backlog Spin-Off

4:25 PM MST | March 3, 2008 | Alex Scott

Excelsyn (Holywell, U.K.), a custom synthesis firm, may spin off a backlog of six fields of intellectual property (IP) into a separate company, CW has learned. The IP relates to four distinct areas of biotransformation technology and two organometallic catalyst technologies. Shott: May approach venture capital firms. Excelsyn does not currently have access to enough capital to fully exploit the technology backlog and a spin-off appears to be the best course of action, Excelsyn managing director and founder Ian Shott says. Excelsyn will consider options during the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa